Search details
1.
Systematic identification of molecular subtype-selective vulnerabilities in non-small-cell lung cancer.
Cell
; 155(3): 552-66, 2013 Oct 24.
Article
in English
| MEDLINE | ID: mdl-24243015
2.
Mode of action and pharmacogenomic biomarkers for exceptional responders to didemnin B.
Nat Chem Biol
; 11(6): 401-8, 2015 Jun.
Article
in English
| MEDLINE | ID: mdl-25867045
3.
Pleiotrophin drives a prometastatic immune niche in breast cancer.
J Exp Med
; 220(5)2023 05 01.
Article
in English
| MEDLINE | ID: mdl-36828390
4.
Epithelial-mesenchymal transition increases tumor sensitivity to COX-2 inhibition by apricoxib.
Carcinogenesis
; 33(9): 1639-46, 2012 Sep.
Article
in English
| MEDLINE | ID: mdl-22678114
5.
Tumor Cells Modulate Macrophage Phenotype in a Novel In Vitro Co-Culture Model of the NSCLC Tumor Microenvironment.
J Thorac Oncol
; 17(10): 1178-1191, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35798240
6.
AXL Inhibitor TP-0903 Reduces Metastasis and Therapy Resistance in Pancreatic Cancer.
Mol Cancer Ther
; 21(1): 38-47, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34675118
7.
Smac mimetic-derived augmentation of chemotherapeutic response in experimental pancreatic cancer.
BMC Cancer
; 11: 15, 2011 Jan 12.
Article
in English
| MEDLINE | ID: mdl-21226944
8.
AXL Is a Key Factor for Cell Plasticity and Promotes Metastasis in Pancreatic Cancer.
Mol Cancer Res
; 19(8): 1412-1421, 2021 08.
Article
in English
| MEDLINE | ID: mdl-33811159
9.
Hemolysis-associated phosphatidylserine exposure promotes polyclonal plasmablast differentiation.
J Exp Med
; 218(6)2021 06 07.
Article
in English
| MEDLINE | ID: mdl-33830176
10.
The acellular fraction of stored platelets promotes tumor cell invasion.
J Surg Res
; 153(1): 132-7, 2009 May 01.
Article
in English
| MEDLINE | ID: mdl-18541268
11.
Human pancreatic cancer cell exosomes, but not human normal cell exosomes, act as an initiator in cell transformation.
Elife
; 82019 05 28.
Article
in English
| MEDLINE | ID: mdl-31134894
12.
Targeting TGFßR2-mutant tumors exposes vulnerabilities to stromal TGFß blockade in pancreatic cancer.
EMBO Mol Med
; 11(11): e10515, 2019 11 07.
Article
in English
| MEDLINE | ID: mdl-31609088
13.
Small-Molecule Inhibition of Axl Targets Tumor Immune Suppression and Enhances Chemotherapy in Pancreatic Cancer.
Cancer Res
; 78(1): 246-255, 2018 01 01.
Article
in English
| MEDLINE | ID: mdl-29180468
14.
Extra-mitochondrial prosurvival BCL-2 proteins regulate gene transcription by inhibiting the SUFU tumour suppressor.
Nat Cell Biol
; 19(10): 1226-1236, 2017 Oct.
Article
in English
| MEDLINE | ID: mdl-28945232
15.
Identification of lipid-phosphatidylserine (PS) as the target of unbiasedly selected cancer specific peptide-peptoid hybrid PPS1.
Oncotarget
; 7(21): 30678-90, 2016 May 24.
Article
in English
| MEDLINE | ID: mdl-27120792
16.
Tris DBA palladium is highly effective against growth and metastasis of pancreatic cancer in an orthotopic model.
Oncotarget
; 7(32): 51569-51580, 2016 08 09.
Article
in English
| MEDLINE | ID: mdl-27438140
17.
Fibulin-5 Blocks Microenvironmental ROS in Pancreatic Cancer.
Cancer Res
; 75(23): 5058-69, 2015 Dec 01.
Article
in English
| MEDLINE | ID: mdl-26577699
18.
Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis.
Cancer Res
; 75(18): 3699-705, 2015 Sep 15.
Article
in English
| MEDLINE | ID: mdl-26206560
19.
Collagen signaling enhances tumor progression after anti-VEGF therapy in a murine model of pancreatic ductal adenocarcinoma.
Cancer Res
; 74(4): 1032-44, 2014 Feb 15.
Article
in English
| MEDLINE | ID: mdl-24346431
20.
Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFß activation.
PLoS One
; 7(2): e31384, 2012.
Article
in English
| MEDLINE | ID: mdl-22348081